BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 2209216)

  • 1. The effect of low-dose estrogen and progestogen on menopausal symptoms and urinary excretion of calcium.
    Lin SQ; Ge QS; Yao FY; Feng DD; Wang HL
    Chin Med J (Engl); 1990 Aug; 103(8):652-7. PubMed ID: 2147000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of nutrition, age and vitamin D status on fasting urinary excretion of calcium in postmenopausal women].
    Rubinacci A; Lodigiani S; Sirtori P; Tessari L
    Minerva Med; 1992 Oct; 83(10):601-8. PubMed ID: 1461531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective one-year study of estrogen and progestin in postmenopausal women: effects on clinical symptoms and lipoprotein lipids.
    Sherwin BB; Gelfand MM
    Obstet Gynecol; 1989 May; 73(5 Pt 1):759-66. PubMed ID: 2704504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Estrogenic vaginal creams and calciuria in postmenopausal women].
    Blum M; Ariel J; Peri J
    Rev Fr Gynecol Obstet; 1984; 79(7-9):571-3. PubMed ID: 6098955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of estrogen (Premarin) replacement therapy on serum level of total estrogen and urinary excretion of calcium and hydroxyproline in postmenopausal Chinese women.
    Ouyang PC; Chow SN; Huang SC; Hsieh CY
    Proc Natl Sci Counc Repub China B; 1986 Jul; 10(3):162-6. PubMed ID: 3022320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Action of low-dose estrogen and progestogen on the relief of climacteric symptoms and excretion of urinary calcium].
    Lin SQ
    Zhonghua Fu Chan Ke Za Zhi; 1990 Jul; 25(4):198-201, 251. PubMed ID: 2209216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progestogen deficiency and endometrial cancer risk.
    Schindler AE
    Maturitas; 2009 Apr; 62(4):334-7. PubMed ID: 19231117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oestrogens and endometrial hyperplasia.
    Thom MH; Studd JW
    Br J Hosp Med; 1980 May; 23(5):506, 508-9, 511-3. PubMed ID: 6992895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contraception for the perimenopausal patient.
    Upton GV
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):207-27. PubMed ID: 3306520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose estrogen therapy for menopausal women: a review of efficacy and safety.
    Crandall C
    J Womens Health (Larchmt); 2003 Oct; 12(8):723-47. PubMed ID: 14588124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for estrogen and progestogen use in peri-and postmenopausal women: October 2004 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2004; 11(6 Pt 1):589-600. PubMed ID: 15545786
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.